top of page

Restore mobility with ORTHOFLEX®

A new generation of viscosupplements

ORTOBRAND INTERNATIONAL, manufactures and distributes products based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body, used for the affected synovial joint.

It all started with a desire to help people in need and to be able to understand that a medical device is not just a product, but rather a chance to return to a normal life. ORTOBRAND team’s objective is to develop international business by establishing partnerships with specialized foreign distributors all over the world.


If you are interested in such a partnership, please use the contact form from our website.

Thank you for your interest in our products and services.

Quality products.


Orthoflex one is produced according to Good Manufacturing Practice (GMP) and ISO13485 being certified as a system with high quality ingredients, CE marked medical device being in accordance with the European Directive 93/42/EE.

Advanced Technology


The manufacturing in compliance with Romanian law no 95/2006 regarding medicines for human use. Valid Manufacturing Authorization, in full compliance with GMP issued by the National Medicine and Medical Devices Agency.

Manufacturing operations for investigational medicinal products include total or partial, certification and batch release, import, storage and distribution and tests (microbiological and physical-chemical) for quality control.

News //

Make a Splash with Water Workouts


Looking for a way to liven up your exercise routine? Try leaving dry land.



Flexibility training videos


These exercises help relieve stiff joints and improve your range of motion.





Some extra tips to help you with the program and enjoying an active lifestyle.



Anchor 1
Video //

ORTHOFLEX one® injection process

Medical investigation, approved result.

ORTOBRAND has a method that is currently unique with regard to the combination of its advantages. The raw material selected according to the highest quality aspects is crosslinked in a special way. The products are thus particularly stable in the human body. Natural enzymatic degradation processes are slowed down by the crosslinked and gel-like substance, and by the associated reduction in the molecule surface of the products.


The extraction of hyaluronic acid (non-animal origin) through biofermentation also reduces the likelihood of immune responses to a minimum. ORTOBRAND products have an optimized injection behavior that is reflected in the thixotropic properties of the hyaluronic acid from ORTOBRAND.

bottom of page